This study was designed to test the effects of pursed lips breathing (PLB) during exercise in patients with chronic obstructive pulmonary disease (COPD) who did not spontaneously perform PLB. Sixtynine COPD patients, mean FEV, (SD) 1.09 (0.5), age 68 (51-83) were recruited to the study. They performed three incremental shuttle walk tests (ISWT). The first walk was designed to identify natural PLBs and the next two walks were performed in a random order; ISWT + PLB or ISWT whilst breathing normally. Measures of respiratory rate (RR), breathlessness and oxygen saturation were taken before and after walks. Data was analysed using the t-test. Fifteen patients demonstrated PLB on baseline ISWT and were therefore excluded from further walking tests although baseline data was included in the analysis. There was no significant difference between walks, mean (SD), 298.5 (173.7) PLB and non-PLB; 292.5 (161.9) nor any difference in dyspnoea. There was a significant reduction in end exercise RR and recovery time with PLB, mean difference (95% CI); 6.2 (4.5 -7.9) and 24.9 (2.8-47.0) seconds, respectively. Patients who showed a good response with the PLB walk (41%) had significantly higher baseline breathlessness, Borg score, mean (SD), 1.5 (1.0) versus 0.74 (0.96) (P = 0.02). Natural PLB patients demonstrated lower exercise tolerance on the baseline walk (P = 0.01) and a trend towards greater resting breathlessness than those who did not. This study shows PLB during exercise and recovery results in lower post exercise RR and speeds return to pre exercise breathlessness, compared with exercise and non-PLB. Reductions in RR appear to be greatest in those patients with resting breathlessness. Chronic Respiratory Disease 2005; 2: 67-72
Introduction
There are approximately 600 000 people in the United Kingdom with chronic obstructive pulmonary disease (COPD). For these patients one of the most incapacitating symptoms reported is dyspnoea on exertion, often experienced during simple tasks such as walking around at home.1 A variety of techniques have been used to address activity limitation and severe dyspnoea, one such technique is instruction in breathing patterns. The use of relaxed breathing (abdominal/ diaphragmatic breathing) is anecdotally recommended. However, evidence suggests that, for patients with more severe COPD, abdominal/diaphragmatic breathing may in fact be disadvantageous.2 Pursed lips breathing (PLB), on the other hand, has been identified as a potential mechanism for reducing dyspnoea during daily activities. 3 Studies have consistently documented a lowering of the respiratory rate at rest4 -6 and during exercise in patients with COPD. 4 In addition, lowering of the RR appears to be supported by a reduction in maximal oxygen consumption (VO2 max)6 and subjective improvement was found to be greater in those with the biggest reduction in post exercise RR.4 This suggests that PLB may be a more effective pattern of breathing than natural breathing and that benefits may extend to improvements in exercise tolerance. There is evidence that during both rest and exercise PLB is associated with an increase in tidal volume and a reduction in minute ventilation.4 '7 It is thought that PLB may contribute to alleviating the phenomenon of airway E-mail: rgarrod@hscs.sghms.ac.uk closure in patients with COPD and decrease in transpulmonary resistance.8 However, although, Mueller and colleagues demonstrated improvement in arterial blood gases and oxygen saturation when PLB was performed at rest, there were no similar improvements when performed during exercise.4 Breslin and colleagues also investigated breathing mechanics during PLB and showed greater activity in rib cage muscles compared with diaphragmatic activity.9 They suggested this provides a protective function to the diaphragm hence ameliorating dyspnoea.9"10 Roa and colleagues, in abstract data, found similar patterns of respiratory muscle activity during PLB but also measured work of breathing, as estimated from gastric and pleural pressures.5 Interestingly, they found that although minute ventilation and RR were reduced with PLB, work ofbreathing was greater. The mechanism by which PLB relieves dyspnoea and in which patients it is effective remains controversial.'1 In particular, the effects of its use during maximal exercise are poorly explored and efficacy has not been determined. With the development of pulmonary rehabilitation services patients are routinely being advised to exercise to higher levels of dyspnoea.12 Where patients naturally adopt the technique and perceive benefit it would be inadvisable and indeed impossible to prevent them using PLB. However, guidance recommends teaching all patients PLB as part of an exercise programme13 whilst the evidence for this is poor. Clearly if therapists are teaching patients to use PLB during exercise there needs to be some evidence of the expected outcome. Based on these expected outcomes clinicians require guidance with respect to which patients benefit most. This study is concerned with the clinical question of whether there are benefits in maximal exercise tolerance and dyspnoea when using PLB during exercise and throughout recovery. Furthermore, we hope to be able to identify suitable patients for whom PLB may be of most benefit when spontaneous PLB has not been previously adopted. Those patients with COPD who do not naturally adopt the technique will be investigated.
Methodology
The study was performed across two sites according to standardised instruction. Patients with COPD referred to pulmonary rehabilitation at Mayday University Hospital and St George's NHS Trust were recruited to the study. FEV 1/FVC ratio and medical referral letter confirmed diagnosis of obstructive disease. Patients were excluded if they had musculoskeletal problems that limited mobility or any other comorbidities which would affect their ability to undertake exercise tests, e.g., unstable angina, intermittent claudication, neurological problems limiting cognition/mobility. No patients were on long term oxygen or domiciliary noninvasive positive pressure ventilation. Patients were advised to adhere to their normal medication routine and no additional medication was taken during the study period. Patients were medically stable and free of exacerbation for more than three weeks (as defined by a change to pharmacological therapy). Ethics approval was obtained from both Local Research Ethics Committees. Written consent was received from all patients prior to commencement.
Assessments Lung function
Spirometry was performed using hand held Spirometry (Microloop ML 3535, Micromedical Ltd.). The best of three attempts was taken and all researchers were trained in the use of spirometry according to American Thoracic Society guidelines.14 Verbal encouragement was standardized for all tests. Patients demonstrated a diagnosis of COPD according to British Thoracic Society Guidelines.'5
Exercise capacity
Exercise capacity was assessed using the ISWTwhich is a maximal, standardized externally paced incremental exercise test. 16 The test involves the patient completing 10 metre shuttles at a speed externally paced via the use of a tape recording. The speed of shuttles increases each minute until the patient can no longer match the pace or reaches a symptom limiting maximum. The instructions are standardized and delivered via the tape recording. Recent abstract data has reported the minimum clinically important difference for ISWT as a change of mean (95% CI) as 48 m (33.6-63.6).17 A baseline walk was performed whilst the subject used their normal breathing pattern with no special instructions. This was considered a practice walk and was also used to establish the prevalence of spontaneous PLB. Exclusion was made on the basis of PLB on this walk or if the technique was performed incorrectly. Exclusion of patients on these grounds was made using standardized criteria; that PLB was noted by two researchers 5 -10 times during the final minute of the walking test or during recovery. PLB was defined as demonstrating four points; inhalation through the nose, expiration at least three to four times longer than inspiration, lips pursed or puckered during exhalation and cheeks not puffed out.
A further two walking tests were then performed, with and without PLB. The order of the walking tests were randomly assigned using computer generated codes. The test walks were performed at least 20 minutes after the practice walk and not before resting breathlessness, respiratory rate and arterial saturation had returned to pretesting levels. The respiratory physiotherapists in both centres taught the technique according to standardized written and diagrammatic instruction. Verbal instructions were that the patient should 'blow the air out through your pursed lips in a finn and steady stream. Count to four in your head. Your breath out should take three to four times as long as your breath in. Make sure you don't puff out your cheeks when breathing out'. Correction was provided where necessary and encouragement given to use the technique throughout the walk. Patients were instructed to continue using PLB technique during recovery from the PLB walk test. In each site the physiotherapist who taught the breathing technique performed the walking test under PLB conditions whilst a different therapist performed the control test. Intra reliability of the ISWT has previously been demonstrated and there is no evidence of fatigue between successive tests. 18 The therapists were blinded to the results ofeach test and a fifth investigator not present at the assessments analysed the data. Percutaneous oxygen saturation (SpO2) and heart rate (HR) were measured immediately following each walk using a pulse-oximeter (Minolta Pulsox 3, AVL Instruments, Schafihausen, Switzerland).
Dyspnoea, respiratory rate and perception ofdiscomfort
The patients were asked to indicate their level of breathlessness using the Modified Borg Scale ofperceived breathlessness before and immediately after each walk. 19 This was done in a standardized manner by the physiotherapist observing the walk. Respiratory rate (RR) was measured before and after each walk over one minute. The researcher observing the walk recorded time to recovery of breathlessness. Patients were instructed to inform the researcher once breathlessness had returned to preexercise levels using the Modified Borg Scale. Percutaneous saturation was also measured during this period and the time to recovery was confirmed when breathlessness and arterial saturation levels had both returned to pre-exercise. Additionally patients were asked at the end of the walks, 'which test, if any, did you feel was the most comfortable'.
Statistical analysis
Normality was determined by analysis of histograms, all data, with the exception ofbreathlessness scores and percutaneous saturation levels were normally distributed. Sample size calculation was based on previous data collected from our group in a different population. Using mean PLB (SD) walk of 278 m (105) and assuming an increase in walk of 60 m at power 80% and P < 0.05 it was estimated that 49 patients would be needed to detect a clinically relevant difference. Differences in variables between PLB walk and normal breathing walk were determined using the paired t-test, SaO2 and breathlessness data were analysed using the equivalent non parametric tests, however, parametric testing resulted in very similar P-values and hence confidence intervals are presented. Nonparametric tests were used to explore variables related to preference of walk. Post hoc analysis was based on arbitrarily defined 'responders' and 'nonresponders'. Responders were described as those who had a reduction in postexercise RR of greater than six during the PLB walk compared with those who did not. Differences between these groups and between those that naturally adopted pursed lips breathing and those that did not were analysed using the unpaired t-test.
Results

Patients
Sixty-nine patients with a diagnosis of COPD were recruited to the study, mean FEV1 (SD) 1.09 L (0.5), mean FEV, percent predicted (SD); 44.3% (18.4) , mean FVC (SD) 2.1 L (0.8), mean age (range); 68 (51-83). Fifteen patients showed natural PLB on the screening walk and were therefore excluded from randomisation and further walking tests. However, baseline data on these patients was included in evaluation of the characteristics of natural PLBs (Table 1) . A further five patients were unable to perform PLB with instruction and were similarly excluded from additional walks and one patient was excluded because FEVy /FVC ratio was greater than 75%. Forty-eight patients completed three walking tests and all components of the study.
Patients who naturally performed PLB compared with those that did not showed statistically significantly lower baseline exercise tolerance and a trend towards more severe airway obstruction and greater resting breathlessness (Table 1) .
Respiratory rate, heart rate, exercise tolerance and breathlessness Table 2 shows the results of the two walking tests.
When patients performed maximal exercise using PLB the end RR was significantly lower than when breathing normally. The change in RR as a result of exercise was also significantly lower during the PLB walk, mean increase in RR (SD); 6.6 (6.0) and 1.7 (6.2) during the normal walks and PLB walk respectively, mean difference (95% CI); 4.9 (2.8-6.9). In addition, the time taken to recover to pre exercise breathlessness levels was significantly reduced when using PLB during recovery, compared with normal breathing, mean difference (95% CI) 24.9 (2.8-47.0) seconds. However, these differences did not translate into improvements in exercise tolerance or in the perception of dyspnoea ( Table 2) .
Perception of comfort
Data was unavailable on eight patients, hence responses were obtained in 40 patients. There were no differences between walks for patient perception of comfort, indeed 47.5% reported no preference, 45% reported a preference for PLB, a small minority reported the non-PLB walk to be most comfortable (7.5%).
Characteristics of responders
Six breaths per minute (bpm) was identified as the mean difference between normal and PLB walk, this was then taken to define a positive response to PLB. Table 3 shows the different baseline characteristics for those patients that demonstrated a reduction in RR of more than six (responder) or less than six bpm (nonresponder). Modified Borg Scale of perceived breathlessness score was significantly higher in the responder group compared to the nonresponder (Table 3 ). There were no other statistically significant differences between the groups although there was a trend for lower FEV1% predicted and lower baseline walking distance in the group that showed a good response to PLB.
Discussion
This is an original study designed to evaluate the effects of PLB during exercise in patients with COPD. This is the first study to exclude patients who naturally use PLB and therefore consider the benefits in a population germane to the clinical question. Methodological limitations of the study require some preliminary discussion. Our sample size calculation was based on previous work from a group of patients similarly excluded if they showed natural PLB on a test walk. We have used a sample size based on a difference in walking distance of 60 m which reflects a large clinical improvement. Indeed, the very similar walking distance we found between PLB and normal breathing walks indicates that for PLB to show even a small clinical benefit in terms of increased exercise tolerance an unrealistically large sample size will be required. We chose to use a maximal walking test rather than a submaximal test since patients are routinely being asked to exercise to maximal levels, hence we felt this test reflected clinical practice with respect to newer interventions such as pulmonary rehabilitation. In this study patients with COPD, who do not naturally perform PLB, showed no improvement in terms of distance walked nor of dyspnoea perceived when maximally exercising whilst using PLB. However, as with other authors we have shown a significant reduction in end exercise respiratory rate with the addition of PLB,4'7 and importantly the return to pre-existing levels of breathlessness was, on average, ten percent quicker after the PLB walk. The clinical benefit of this is unclear, since dyspnoea was not reduced and the majority of patients were unable to state a clear preference for one walk over another. Although, for those patients who did report a preference, the majority were in favour of PLB but we were unable to identify the variables that explained this. Of course, the idea of 'comfort' and preference is subjective and open to confusion, moreover the results from the Modified Borg Scale may be subject to recall bias. All patients were asked their breathlessness at the end of the initial screening walk, the relatively short period of 20 minutes between walks may have meant that patients remembered their previous answer rather than accurately reflecting small changes in sensation between walks. An altemative study design would be to collect the data over a number ofdifferent visits. In the study by Mueller and colleagues4 preference for PLB was associated with greater reductions in end exercise respiratory rate. We therefore arbitrarily chose to use reduction in respiratory rate as a way of identifying potential 'responders' to PLB. What was interesting in our study, is that based on the magnitude of change in respiratory rate, those that did well with PLB were clearly those with greatest breathlessness at rest. Other variables which might have been expected to determine response such as lung function and exercise tolerance showed a trend towards greater impairment but were not statistically different. This of course, may represent a type II error or more cautiously, our finding of significantly greater breathlessness may represent a type I error. However, a similar picture emerged when evaluating the baseline characteristics of patients who were excluded from the study on the grounds of natural PLB. Whilst variables such as dynamic hyperinflation or arterial blood gases were not measured in this study our finding that oxygen saturation did not differ between PLB and normal walks was in accordance with Mueller and colleagues,4 who showed no change in blood gases with PLB during exercise. We are unable and nor did we intend to, explain the mechanism by which PLB reduces respiratory rate, however this study takes our knowledge forwards with respect to which patients may be appropriate for instruction and indeed may help refine inclusion criteria for future studies of PLB. The mean resting Modified Borg Scale of perceived breathlessness was twice as high in the responder group compared with the nonresponders. Whilst resting breathlessness is unlikely to be the only parameter predicting benefit, the finding that only four patients out of our 21 responders reported no breathlessness at rest, compared with 19 out of our 28 poor responders, suggests that a trial of PLB in patients breathless at rest may be fruitful.
Whilst we can be fairly sure that PLB is effective in lowering the resting respiratory rate and as our data confirms, breathing frequency post exercise, why and for whom it reduces perception of breathlessness is still unclear. In addition we require further clarification of the clinical value of a reduction in breathing rate and improvement in recovery time. Recent authors have arbitrarily suggested an improvement of 30 seconds may be clinically relevant,20 similar to our mean improvement of 25 seconds. What our data demonstrates though, is that, assuming there is clinical relevance of reduced respiratory rate and improved recovery time, patients who are breathless at rest are the ones most likely to achieve the greatest magnitude in benefit. This is particularly important when planning evidenced based therapeutic interventions.
Future research is recommended to test this hypothesis in a prospective fashion and to provide more detailed description of patients. Ideally, measures of hyperinflation, chest wall and abdominal excursion, air flow and volume would be provided to enhance our understanding of such techniques.
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